NFKB1 and urinary bladder carcinoma: Inamoto et al. primarily investigated the effect of 1,1-bis(3′-indolyl)-1-(p-chlorophenyl)methane (C-DIM), a Nurr1 activator, that via inhibiting the NF-κB signaling pathway reduced tumor growth of bladder cancer cells in vitro [37].